Brief: India's Windlas Biotech Sept-Quarter Consol Net Profit Rises
08/11/2022 09:21
Nov 8 (Reuters) - Windlas Biotech Ltd WINL.NS :
* SEPT-QUARTER CONSOL NET PROFIT 121.9 MILLION RUPEES VERSUS
83
MILLION RUPEES
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.33 BILLION
RUPEES
VERSUS 1.15 BILLION RUPEES
* APPROVED SHARE BUYBACK UPTO 250 MLN RUPEES
* BUYBACK PRICE 325 RUPEES PER SHARE
Source text for Eikon: ID:nBSEbcH3QN
Further company coverage: WINL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windlas Biotech
See all newsBrief: Windlas Biotech Approves Buyback Of Shares Worth Up To 470 Million Rupees
Brief: Windlas Biotech Dec-Quarter Consol Net Profit 150 Million Rupees
Brief: Windlas Biotech June-Quarter Consol Net Profit 176.6 Million Rupees
Brief: Windlas Biotech Gets GMP Certification For New Injectable Facility
Brief: Windlas Biotech June-Quarter Consol Net Profit 134.8 Mln Rupees